18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Background: Traditional measurements of vaccine coverage at specific ages can mask poor vaccine timeliness. However, optimal measurement of timing is unclear due to variations in countries’ recommended vaccination schedules and lack of a commonly accepted standard for “timeliness”. We conducted a systematic review of literature on vaccine timeliness and delay in low- and middle-income countries from 2007 to 2017.

          Methods: A search of articles published between January 1 2007 and December 31 2017, was performed in PubMed, EBSCOhost, and Embase.

          Results: 67 papers were included, of which 83% used a categorical measure of delay and 41% evaluated continuous delay. The most common age at assessment was 1 month, with earlier age benchmarks typically used with birth doses.

          Conclusions: Categorical definitions of vaccination timing vary widely, with benchmarks of delay varying from days to weeks to months. Use of a continuous measure of vaccine delay may be more informative and comparable.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          The 5As: A practical taxonomy for the determinants of vaccine uptake.

          Suboptimal vaccine uptake in both childhood and adult immunisation programs limits their full potential impact on global health. A recent progress review of the Global Vaccine Action Plan stated that "countries should urgently identify barriers and bottlenecks and implement targeted approaches to increase and sustain coverage". However, vaccination coverage may be determined by a complex mix of demographic, structural, social and behavioral factors. To develop a practical taxonomy to organise the myriad possible root causes of a gap in vaccination coverage rates, we performed a narrative review of the literature and tested whether all non-socio-demographic determinants of coverage could be organised into 4 dimensions: Access, Affordability, Awareness and Acceptance. Forty-three studies were reviewed, from which we identified 23 primary determinants of vaccination uptake. We identified a fifth domain, Activation, which captured interventions such as SMS reminders which effectively nudge people towards getting vaccinated. The 5As taxonomy captured all identified determinants of vaccine uptake. This intuitive taxonomy has already facilitated mutual understanding of the primary determinants of suboptimal coverage within inter-sectorial working groups, a first step towards them developing targeted and effective solutions.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Pneumococcal vaccines WHO position paper--2012.

            (2012)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature.

              Immunization programs frequently rely on household vaccination cards, parental recall, or both to calculate vaccination coverage. This information is used at both the global and national level for planning and allocating performance-based funds. However, the validity of household-derived coverage sources has not yet been widely assessed or discussed. To advance knowledge on the validity of different sources of immunization coverage, we undertook a global review of literature. We assessed concordance, sensitivity, specificity, positive and negative predictive value, and coverage percentage point difference when subtracting household vaccination source from a medical provider source. Median coverage difference per paper ranged from -61 to +1 percentage points between card versus provider sources and -58 to +45 percentage points between recall versus provider source. When card and recall sources were combined, median coverage difference ranged from -40 to +56 percentage points. Overall, concordance, sensitivity, specificity, positive and negative predictive value showed poor agreement, providing evidence that household vaccination information may not be reliable, and should be interpreted with care. While only 5 papers (11%) included in this review were from low-middle income countries, low-middle income countries often rely more heavily on household vaccination information for decision making. Recommended actions include strengthening quality of child-level data and increasing investments to improve vaccination card availability and card marking. There is also an urgent need for additional validation studies of vaccine coverage in low and middle income countries. Copyright © 2013. Published by Elsevier Ltd.
                Bookmark

                Author and article information

                Journal
                Hum Vaccin Immunother
                Hum Vaccin Immunother
                KHVI
                khvi20
                Human Vaccines & Immunotherapeutics
                Taylor & Francis
                2164-5515
                2164-554X
                2019
                12 June 2019
                12 June 2019
                : 15
                : 12
                : 2790-2805
                Affiliations
                [a ]Department of Epidemiology, School of Public Health, University of Michigan , Ann Arbor, MI, USA
                [b ]Department of Internal Medicine, Division of Infectious Disease, University of Michigan Medical School , Ann Arbor, MI, USA
                Author notes
                CONTACT Matthew Boulton mboulton@ 123456umich.edu Department of Epidemiology, School of Public Health, University of Michigan , 1415 Washington Heights, Ann Arbor, MI 48109, USA
                Author information
                http://orcid.org/0000-0002-3155-6058
                http://orcid.org/0000-0003-4691-7802
                Article
                1616503
                10.1080/21645515.2019.1616503
                6930087
                31070992
                acb9136b-b641-4583-bfe4-d65f5af16ba8
                © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

                History
                : 1 February 2019
                : 10 April 2019
                : 1 May 2019
                Page count
                Figures: 5, Tables: 3, References: 96, Pages: 16
                Funding
                Funded by: National Institute of Allergy and Infectious Diseases 10.13039/100000060
                Award ID: K01AI137123
                ALW’s salary was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number K01AI137123. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health;National Institute of Allergy and Infectious Diseases [K01AI137123];
                Categories
                Review

                Molecular medicine
                vaccine timeliness,vaccine coverage,expanded program on immunization
                Molecular medicine
                vaccine timeliness, vaccine coverage, expanded program on immunization

                Comments

                Comment on this article